Back to 
Susquehanna International Group, LLP
Susquehanna International Group, LLP
TVRD
1 quarters
Position history for Susquehanna International Group, LLP's holdings in Tvardi Therapeutics, Inc.
Yes. Susquehanna International Group holds 33,165 shares of TVRD (Tvardi Therapeutics), worth $63,014, as of its Q2 2026 13F filing. It opened the position in Q2 2026.
Current Value
$63,014
Current Shares
33,165
Total Value Change
$0
Total Shares Change
0
Quarter-by-Quarter History
Other major holders of TVRD: Vanguard Group Inc., BlackRock, Inc., Geode Capital Management, LLC